Dualitas Therapeutics

Dualitas Therapeutics is a developer of a bispecific antibody therapeutic platform specifically designed to address immunology and inflammation. The company’s platform integrates discovery and rapid candidate optimization, identifying novel bispecific antibody candidates by functionally screening the entire cell surface, enabling patients with immune and inflammatory diseases to access treatments with greater pharmacological activity and more meaningful clinical benefits.